Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland
High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (≥65 years) myeloma patients: comparison with younger patients treated on the same protocol
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study
Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist
Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads
T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infection
Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus
Increase in allergy following donor lymphocyte infusions